Concepedia

Manyi Xu

MX

Statistics

Publications

7

Citations

156

H-Index

7

Active since

2017

Affiliations

China Pharmaceutical University(Current)

Zhejiang Chinese Medical University

Zhejiang Cancer Hospital

Wenzhou Medical University

Manyi Xu is an author at China Pharmaceutical University specializing in medicinal chemistry, pharmacy, and drug discovery.

ORCID

Publications per year

2017–2023

7

Publications

7

Discovery of Novel Celastrol Derivatives as Hsp90–Cdc37 Interaction Disruptors with Antitumor Activity

Na Li, Manyi Xu, Bing Wang et al. · Journal of Medicinal Chemistry · 2019 · 42 citations

, , +16

Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity

Na Bao, Jinfeng Ou, Manyi Xu et al. · European Journal of Medicinal Chemistry · 2017 · 27 citations

, , +13

Design, synthesis and antitumor evaluation of novel celastrol derivatives

Manyi Xu, Na Li, Zihao Zhao et al. · European Journal of Medicinal Chemistry · 2019 · 26 citations

, , +10

Discovery of Novel Celastrol–Imidazole Derivatives with Anticancer Activity <i>In Vitro</i> and <i>In Vivo</i>

Na Li, Manyi Xu, Lulu Zhang et al. · Journal of Medicinal Chemistry · 2022 · 24 citations

, , +11

Discovery of novel NO-releasing celastrol derivatives with Hsp90 inhibition and cytotoxic activities

Na Li, Manyi Xu, Na Bao et al. · European Journal of Medicinal Chemistry · 2018 · 13 citations

, , +7

1–5 of 7